Moreover, PI3K inhibition can result in hyperglycaemia as PI3K mediates cellular responses to insulin, which leads to an increasing release of insulin in a feedback manner and re-activate PI3K pathway in tumor models in mice, thus ultimately causing PI3Ki resistance (Hopkins et al., 2018). The gene discussed is INS; the disease is Hyperglycemia.